Spleen Preserving Surgery for Splenic Hydatidosis: A Cohort Study on Short and Long-Term Outcomes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

18 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-01-01

Study Completion Date

2021-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This retrospective cohort study examines the effectiveness of minimally invasive spleen-preserving surgeries compared to total splenectomy for treating primary splenic hydatidosis in Jordan. Covering 18 patients from January 2015 to June 2021, the research highlights similar recurrence rates between both surgical approaches, emphasizing the benefits of spleen preservation in maintaining immune function and reducing septic risks, particularly in pediatric patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Splenectomy During Whole Liver Transplantation

NCT03609411

End Stage Liver Disease

COMPLETED

Ultrasound Elastography Assessment of Spleen and Liver Stiffness Before and After Transjugular Intrahepatic Portosystemic Shunt (TIPS) Procedure

NCT03427164

Portal Hypertension

COMPLETED NA

Impact of Percutaneous Cholecystostomy in the Management of Acute Cholecystitis.

NCT05153031

Acute Cholecystitis Percutaneous Cholecystostomy

COMPLETED

SpHincterotomy for Acute Recurrent Pancreatitis

NCT03609944

Pancreatitis Pancreas Divisum Pancreatitis, Acute +2 more

COMPLETED NA

Gallbladder Cryoablation in High-Risk Patients

NCT04915651

Gallbladder Diseases Cholecystitis Biliary Colic +4 more

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study delves into a detailed analysis of 18 cases of primary splenic hydatid cysts treated through spleen-preserving surgeries-laparoscopic partial splenectomy, cystectomy, and cyst deroofing-augmented by albendazole therapy. It presents a comprehensive comparison based on patient demographics, symptoms, surgical details, and outcomes, including complications and recurrence rates. Findings reveal no significant statistical difference in recurrence rates between spleen-preserving methods and total splenectomy, suggesting the viability of less invasive approaches for managing this condition effectively while preserving spleen functionality and minimizing post-operative complications. The study underlines the need for individualized treatment plans and further research with larger cohorts.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spleen-Preserving Surgery Echinococcus Granulosus Infection Hydatid Disease Minimally Invasive Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Minimally Invasive Surgery

Minimally Invasive Surgery : Laparoscopic partial splenectomy, cystectomy, and cyst deroofing.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients (age 14 years or older).
* Diagnosed exclusively with primary, non-recurrent splenic hydatid cysts.

Exclusion Criteria

* Children under 14 years of age.
* Patients in late pregnancy.
* Individuals with recurrent cysts.
* Cases with extra-splenic involvement.
* Patients with less than two years of postoperative follow-up.

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No